When was Vesica Health founded?

Vesica Health was founded in 2022 and raised its 1st funding round 4 years after it was founded.

Where is Vesica Health located?

Vesica Health is headquartered in Irvine, United States.

Who is the current CEO of Vesica Health?

Christopher D Thibodeau of Vesica Health.

How many employees does Vesica Health have?

As of Aug 31, 2026, the latest employee count at Vesica Health is 2.

Is Vesica Health a funded company?

Vesica Health is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Mar 03, 2026.

When was the latest funding round of Vesica Health?

Vesica Health's latest funding was a $***** Series A round on Mar 03, 2026, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $6.48B in funding in 2026 to date.

Where does Vesica Health rank among its competitors?

Vesica Health ranks 2nd amongst 21 active competitors, of which 8 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Vesica Health, which secured $4.47M in Mar, 2026.

Who are the top competitors of Vesica Health?

Vesica Health's top competitors include VitaDX, Nucleix and OncoDiag. Among them, Vesica Health secured the most recent funding round in March, 2026.

Vesica Health - 2026 Company Profile, Team, Funding & Competitors

Q: Is Vesica Health an acquired company?

Vesica Health got acquired by Photocure on Jun 04, 2026.

Company Details

Provider of noninvasive tests to improve the early detection and treatment of bladder cancer for physicians and hematuria patients. They aim to transform the management of hematuria and enhance clinical decisions.

Website: www.vesicahealth.com/
Email ID: *****@vesicahealth.com
Phone Number: +1 **********

Key Metrics

Founded Year

2022

Location

Irvine, United States

Stage

Acquired

Total Funding

$4.47M in 1 round

Latest Funding Round

Series A, Mar 03, 2026, $*****

Ranked

2^nd among 21 active competitors

Employee Count

2 as on Aug 31, 2026

Similar Companies

VitaDX & 24 more

Exit Details

Acquired by Photocure (Jun 04, 2026)

View Vesica Health's full profile

Vesica Health got acquired by Photocure on Jun 04, 2026 at an acquisition amount of $*****.

Click here to take a look at Vesica Health's acquisition in detail

Vesica Health has raised a total funding of $4.47M over 1 round.

Here is the list of recent funding rounds of Vesica Health:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 03, 2026	3004735	Series A	7706753	6238397	9049340	4610562

Access funding benchmarks and valuations. Sign up today!

View details of Vesica Health's funding rounds and investors

Vesica Health's employee count trend

Vesica Health has 2 employees as of Aug 26. Here is Vesica Health's employee count trend over the years:

Uncover Vesica Health's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vesica Health include VitaDX, Nucleix and OncoDiag. Here is the list of Top 10 competitors of Vesica Health, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	VitaDX 2015, Evry Courcouronnes (France), Series B	Early diagnostics for bladder cancer	$23.3M	Odyssee Venture, BNP Paribas & 9 others	48/100
2nd	Vesica Health 2022, Irvine (United States), Acquired	Provider of noninvasive tests to improve the early detection and treatment of bladder cancer for physicians and hematuria patients	$4.47M	-	46/100
3rd	Nucleix 2008, Rehovot (Israel), Series C	Developer non-invasive molecular cancer diagnostic tests	$88.5M	RA Capital Management, Sands Capital & 10 others	46/100
4th	OncoDiag 2013, Miserey (France), Series A	Developer of non-invasive cancer diagnostic solutions	$4.2M	Paris Business Angels, Angels Sante & 3 others	36/100
5th	PhageTech 2014, Newport Beach (United States), Series A	Your source for SGP lottery results, data, and Singapore Togel	$2.9M	EvoNexus, Black River & 4 others	36/100
6th	Early Is Good 2019, Indianapolis (United States), Seed	Developer of multi-omic platform for biomarker detection to transform healthcare	$4M	Social Capital, HHS	36/100
7th	InnoTech Precision Medicine 2021, Boston (United States), Funding Raised	Developer of multimodal molecular diagnostic platform for early disease detection	-	HHS	34/100
8th	KDx Diagnostics 2016, Los Gatos (United States), Seed	Provider of urine and bladder test to detect cancer	$1.12M	-	33/100
9th	Sienna Diagnostics 2002, Scoresby (Australia), Public	Developer of in-vitro diagnsotics tests for the detection of cancer	$3.05M	-	33/100
10th	Cellens 2020, Medford (United States), Series A	Developer of non-invasive diagnostic technology for the detection of bladder cancer	$6.94M	IndieBio	32/100